Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Selvi C, Ersoy"'
Autor:
Sook-Ha Fan, Richard A. Proctor, Selvi C. Ersoy, Adhar C. Manna, Ambrose L. Cheung, Friedrich Götz, Henry F. Chambers, Arnold S. Bayer
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 3 (2023)
ABSTRACT Methicillin-resistant Staphylococcus aureus (MRSA) infections are an increasing concern due to their intrinsic resistance to most standard-of-care β-lactam antibiotics. Recent studies of clinical isolates have documented a novel phenotype,
Externí odkaz:
https://doaj.org/article/c1c2842d93614562ab53cc047089aec1
Autor:
Selvi C. Ersoy, Barbara Gonçalves, Gonçalo Cavaco, Adhar C. Manna, Rita G. Sobral, Cynthia C. Nast, Richard A. Proctor, Henry F. Chambers, Ambrose Cheung, Arnold S. Bayer
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 6 (2022)
ABSTRACT Methicillin-resistant Staphylococcus aureus (MRSA) strains pose major treatment challenges due to their innate resistance to most β-lactams under standard in vitro antimicrobial susceptibility testing conditions. A novel phenotype among MRS
Externí odkaz:
https://doaj.org/article/8917d943fcd94570abddfd92810f8294
Autor:
Selvi C. Ersoy, Liana C. Chan, Michael R. Yeaman, Henry F. Chambers, Richard A. Proctor, Kevin C. Ludwig, Tanja Schneider, Adhar C. Manna, Ambrose Cheung, Arnold S. Bayer
Publikováno v:
Antibiotics, Vol 11, Iss 4, p 462 (2022)
Methicillin-resistant Staphylococcus aureus (MRSA) regulates resistance to β-lactams via preferential production of an alternative penicillin-binding protein (PBP), PBP2a. PBP2a binds many β-lactam antibiotics with less affinity than PBPs which are
Externí odkaz:
https://doaj.org/article/329a3c32a6454aac89e76ce5f344b0ce
Autor:
Selvi C. Ersoy, Warren E. Rose, Robin Patel, Richard A. Proctor, Henry F. Chambers, Ewan M. Harrison, Youngju Pak, Arnold S. Bayer
Publikováno v:
Antibiotics, Vol 10, Iss 9, p 1089 (2021)
Antimicrobial susceptibility testing (AST) is routinely used to establish predictive antibiotic resistance metrics to guide the treatment of bacterial pathogens. Recently, a novel phenotype termed “bicarbonate (NaHCO3)-responsiveness” was identif
Externí odkaz:
https://doaj.org/article/9cbc9a6770de490e872e6b7f70073558
Autor:
Selvi C. Ersoy, Douglas M. Heithoff, Lucien Barnes, V, Geneva K. Tripp, John K. House, Jamey D. Marth, Jeffrey W. Smith, Michael J. Mahan
Publikováno v:
EBioMedicine, Vol 20, Iss C, Pp 173-181 (2017)
The emergence and prevalence of antibiotic-resistant bacteria are an increasing cause of death worldwide, resulting in a global ‘call to action’ to avoid receding into an era lacking effective antibiotics. Despite the urgency, the healthcare indu
Externí odkaz:
https://doaj.org/article/9ca3645ab04e4694ae124abdbc6a1b87
Autor:
Sook-Ha Fan, Richard A. Proctor, Selvi C. Ersoy, Adhar C. Manna, Ambrose L. Cheung, Friedrich Götz, Henry F. Chambers, Arnold S. Bayer
Publikováno v:
Microbiology Spectrum.
MRSA infections are increasingly difficult to treat, due in part to their resistance to most β-lactam antibiotics. A novel and relatively common phenotype, termed NaHCO 3 responsiveness, has been identified in which MRSA strains show increased susce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::010b011b937b5d5144385c43c4d5d8db
https://doi.org/10.1128/spectrum.00141-23
https://doi.org/10.1128/spectrum.00141-23
Autor:
Jessica Z. Kubicek-Sutherland, Douglas M. Heithoff, Selvi C. Ersoy, William R. Shimp, John K. House, Jamey D. Marth, Jeffrey W. Smith, Michael J. Mahan
Publikováno v:
EBioMedicine, Vol 2, Iss 9, Pp 1169-1178 (2015)
Current antibiotic testing does not include the potential influence of host cell environment on microbial susceptibility and antibiotic resistance, hindering appropriate therapeutic intervention. We devised a strategy to identify the presence of host
Externí odkaz:
https://doaj.org/article/1f256947ec19422e8a33100fccaeb7a8
Autor:
Selvi C. Ersoy, Barbara Gonçalves, Gonçalo Cavaco, Adhar C. Manna, Rita G. Sobral, Cynthia C. Nast, Richard A. Proctor, Henry F. Chambers, Ambrose Cheung, Arnold S. Bayer
grant from the National Institutes of Health:1RO1-AI146078 (to A.S.B.). LA/P/0140/2020 of the Associate Laboratory Institute for Health and Bioeconomy-i4HB. Methicillin-resistant Staphylococcus aureus (MRSA) strains pose major treatment challenges du
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6856f6206a815535fe56350eaf563cee
https://hdl.handle.net/10362/146097
https://hdl.handle.net/10362/146097
Autor:
Selvi C. Ersoy, Adhar C. Manna, Richard A. Proctor, Henry F. Chambers, Ewan M. Harrison, Arnold S. Bayer, Ambrose Cheung
Publikováno v:
Antimicrobial Agents and Chemotherapy. 66
Methicillin-resistant Staphylococcus aureus (MRSA) strains are a leading cause of many invasive clinical syndromes, and pose treatment difficulties due to their in vitro resistance to most β-lactams on standard laboratory testing. A novel phenotype
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1664de72bc3ea32a2ab2e1e098167a37
https://doi.org/10.1128/aac.00252-22
https://doi.org/10.1128/aac.00252-22
Autor:
Selvi C, Ersoy, Adhar C, Manna, Richard A, Proctor, Henry F, Chambers, Ewan M, Harrison, Arnold S, Bayer, Ambrose, Cheung
Publikováno v:
Antimicrobial agents and chemotherapy. 66(6)
Methicillin-resistant Staphylococcus aureus (MRSA) strains are a leading cause of many invasive clinical syndromes, and pose treatment difficulties due to their
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6e030975d2b0be2de381d0c33d6b7d57
https://pubmed.ncbi.nlm.nih.gov/35575577
https://pubmed.ncbi.nlm.nih.gov/35575577